Delivery Order SPE2DR25D1104-SPE2DR26FK154
Award Date 10/27/25
Potential Completion Date 10/28/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,277.55 to AmerisourceBergen Drug Corp for Barhemsys 5 mg/2 ml vials on August 8, 2025, with completion targeted for August 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction within AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,104.76 to AmerisourceBergen Drug Corp for the supply of Barhemsys 10 mg/4 mL vials on June 1, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under the vendor's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a $21,443.69 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Barhemsys 10 mg/4 mL vials. The contract, which is classified as a child delivery order under a larger indefinite delivery vehicle, carries an ultimate completion date of September 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Barhemsys 5 mg/2 ml vials with a ceiling value of $1,198.52. This is a firm fixed-price delivery order with no set-aside designation, executed competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999.99 million and extends through December 2026. The product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $4,439.09 to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Barhemsys 10 mg/4 ml vials. This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 26, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,221.96 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 5 mg/2 ml vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed price, non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of the drug BARHEMSYS 5 MG/2 ML VIAL 2ML. The contract has a firm fixed price of $1,621.32 and a completion date of July 25, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of...
- The Defense Logistics Agency awarded a $2,554.97 delivery order to AmerisourceBergen Drug Corp for BARHEMSYS 10 mg/4 ml vials on October 17, 2025, with an ultimate completion date of October 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. BARHEMSYS (amisulpride) is an atypical antipsychotic medication used in clinical settings to treat...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4567212297 - BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $1,310.68 and has a completion date of February 11, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,159.02, is for the supply of BARHEMSYS 5 MG/2 ML VIAL 2ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of January 9, 2024. The contract does not have a set-aside designation, indicating open competition....